LAVA Therapeutics NV (LVTX) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.46
-0.35
-0.24
-0.13

Details

Expected EPS
-0.256667
Actual EPS
-0.32
Surprise EPS
-0.06
Surprise Percent
+24.68%

Description

LAVA Therapeutics NV (LVTX) has reported earnings of -0.32 per share for Q3 2025.

0 Comments

Share your thoughts